M. Galmier

发表

Influence of different calcic antagonists on the Caco-2 cell monolayer integrity or “TEER, a measurement of toxicity ?”

C. Lartigue, F. Mathieu, M. Galmier, 2012, European Journal of Drug Metabolism and Pharmacokinetics.

New aldehyde and vinylsulfone proteasome inhibitors for targeted melanoma therapy.

J. Madelmont, J. Chezal, E. Miot-Noirault, 2011, European journal of medicinal chemistry.

Synthesis, radioiodination and in vivo screening of novel potent iodinated and fluorinated radiotracers as melanoma imaging and therapeutic probes.

N. Moins, J. Papon, J. Madelmont, 2013, European journal of medicinal chemistry.

Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.

J. Chezal, E. Moreau, E. Débiton, 2012, European journal of medicinal chemistry.

Biotransformation study of para-substituted phenylpiperazines in beagle dogs by gas chromatography-mass spectrometry.

M. Bastide, M. Galmier, J. Pognat, 1991, Xenobiotica; the fate of foreign compounds in biological systems.

Assessment of 99mTc-NTP 15-5 uptake on cartilage, a new proteoglycan tracer: Study protocol for a phase I trial (CARSPECT)

F. Penault-Llorca, X. Durando, E. Miot-Noirault, 2022, Frontiers in Medicine.

Transepithelial transport of bepridil in the human intestinal cell line, Caco-2, using a “dynamic model”

C. Lartigue, F. Mathieu, M. Galmier, 2003, European Journal of Drug Metabolism and Pharmacokinetics.

Assay of m-chlorophenylpiperazine in plasma and brain of rat by capillary gas chromatography-mass spectrometry.

J. Petit, M. Galmier, J. Chabard, 1990, Journal of chromatography.

Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.

J. Maublant, C. Lartigue, N. Moins, 2008, Journal of medicinal chemistry.

Green HPLC quantification method of lamivudine, zidovudine and nevirapine with identification of related substances in tablets

S. Tarrit, Olivier Mercier, Ousmane Diop, 2022, Green Chemistry Letters and Reviews.

Synthesis, radiolabeling and preliminary in vivo evaluation of multimodal radiotracers for PET imaging and targeted radionuclide therapy of pigmented melanoma.

J. Madelmont, J. Chezal, E. Miot-Noirault, 2015, European journal of medicinal chemistry.

Linker structure-activity relationships in fluorodeoxyglucose chlorambucil conjugates for tumor-targeted chemotherapy.

J. Chezal, E. Miot-Noirault, E. Débiton, 2017, Bioorganic & medicinal chemistry.

Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.

J. Chezal, E. Miot-Noirault, S. Tarrit, 2020, Bioorganic chemistry.

Design, synthesis and in vitro drug release investigation of new potential 5-FU prodrugs.

J. Chezal, E. Débiton, Pierre Daumar, 2011, European journal of medicinal chemistry.

Synthesis and cytotoxic properties of new fluorodeoxyglucose-coupled chlorambucil derivatives.

J. Madelmont, E. Débiton, Bastien Reux, 2008, Bioorganic & medicinal chemistry.

Patatin-Like PLA 2 with Cytotoxicity against Mammalian and Plant Tumour Cells

J. Madelmont, E. Débiton, G. Ledoigt, 2013 .

Simple and sensitive method for determination of metronidazole in human serum by high-performance liquid chromatography.

J. Aiache, J. Petit, E. Beyssac, 1998, Journal of chromatography. B, Biomedical sciences and applications.

High-performance liquid chromatographic determination of phenylephrine and tropicamide in human aqueous humor.

C. Lartigue, J. Aiache, J. Petit, 2000, Biomedical chromatography : BMC.

Spacer optimization of new conjugates for a melanoma-selective delivery approach.

J. Chezal, S. Tarrit, E. Débiton, 2013, Organic and biomolecular chemistry.

Development of a high-performance liquid chromatographic method for the determination of a new potent radioiodinated melanoma imaging and therapeutic agent.

N. Moins, J. Papon, J. Madelmont, 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Synthesis, radiosynthesis, and biological evaluation of new proteasome inhibitors in a tumor targeting approach.

J. Papon, J. Madelmont, P. Labarre, 2008, Journal of medicinal chemistry.

Single photon emission computed tomography/positron emission tomography imaging and targeted radionuclide therapy of melanoma: new multimodal fluorinated and iodinated radiotracers.

R. Boisgard, B. Tavitian, N. Moins, 2011, Journal of medicinal chemistry.

Validation of a reversed-phase liquid chromatographic method for the determination of hydrocortisone phosphate disodium in a gel formulation.

C. Lartigue, J. Aiache, J. Petit, 1999, Journal of pharmaceutical and biomedical analysis.

Identification of degradation products of diclofenac by electrospray ion trap mass spectrometry.

C. Lartigue, J. Madelmont, M. Galmier, 2005, Journal of pharmaceutical and biomedical analysis.

Transepithelial transport of bepridil in the human intestinal cell line, Caco-2, using two media, DMEMc and HBSS.

C. Lartigue, J. Petit, F. Mathieu, 1999, International journal of pharmaceutics.

Development of a freeze-dried kit formulation for the preparation of 99mTc-NTP 15-5, a radiotracer for scintigraphic imaging of proteoglycans.

J. Chezal, E. Miot-Noirault, S. Besse, 2015, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Comparative study of the biotransformation of bepridil analogs in isolated liver cells from one rat. Relationships between structure and in vitro liver toxicity

M. Galmier, J. Pognat, J. Chabard, 1996, European Journal of Drug Metabolism and Pharmacokinetics.

Preliminary studies of new proteasome inhibitors in the tumor targeting approach: synthesis and in vitro cytotoxicity.

J. Madelmont, J. Sauzieres, A. Jarrousse, 2005, Journal of medicinal chemistry.